CCR7 antibody (AA 1-100)

Catalog No. ABIN7090979

This anti-CCR7 antibody is a Mouse Monoclonal antibody detecting CCR7 in WB. Suitable for Human.

Quick Overview for CCR7 antibody (AA 1-100) (ABIN7090979)

Target: CCR7 (Chemokine (C-C Motif) Receptor 7 (CCR7))

Reactivity: Human

Host: Mouse

Clonality: Monoclonal

Conjugate: This CCR7 antibody is un-conjugated

Application: Western Blotting (WB)

Product Details anti-CCR7 Antibody

Binding Specificity: AA 1-100

Predicted Reactivity: Human

Purification: Purified by Protein G.

Immunogen: KLH conjugated synthetic peptide from human CCR7

Isotype: IgG1

Application Details

Application Notes: WB 1:300-5000

Restrictions: For Research Use only

Handling

Concentration: 0.5 μg/μL

Buffer: 0.01M TBS( pH 7.4) with 1 % BSA, 0.02 % Proclin300 and 50 % Glycerol.

Preservative: ProClin

Precaution of Use: This product contains ProClin: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.

Storage: 4 °C,-20 °C

Storage Comment: Shipped at 4°C. Store at -20°C for one year. Avoid repeated freeze/thaw cycles.

Expiry Date: 12 months

Target Details for CCR7

Target: CCR7 (Chemokine (C-C Motif) Receptor 7 (CCR7))

Alternative Name: CCR7

Background:

Synonyms: CCR7_HUMAN, BLR 2, BLR2, C C chemokine receptor type 7, C C CKR 7, CC chemokine receptor 7, CC chemokine receptor type 7, CC CKR 7, CCCKR7, CCR 7, CD 197, CD197, CD197 antigen, CDW197, Chemokine C C motif receptor 7, Chemokine C C receptor 7, Chemokine receptor 7-like protein, EBI 1, EBI1, Ebi1h, EBV Induced G Protein Coupled Receptor 1, Epstein Barr virus induced G protein coupled receptor, Epstein Barr virus induced gene 1, EVI 1, EVI1, Lymphocyte Specific G Protein Coupled Peptide Receptor, MGC108519, MIP 3 beta receptor, MIP3 Beta Receptor.

Background: Receptor for the MIP-3-beta chemokine. Probable mediator of EBV effects on B-lymphocytes or of normal lymphocyte functions.

Gene ID: 1236

UniProt: P32248

Pathways: Regulation of Actin Filament Polymerization, Positive Regulation of Immune Effector Process